Jengufun Lidocaine Knee Patch
NDC Package 69561-008-08
Package Information
Jengufun Lidocaine Knee Patch (lidocaine knee patch) patches is adult and children 12 years of age and over: ■ clean and dry affected area ■ remove film from patch and apply to the skin (see illustration) ■ apply 1 patch at a time to affected area, not more than 3 to 4 times daily ■ remove patch from the skin after at most 8-hour application ■ Children under 12 years of age: consult a doctor. This formulation utilizes a patch delivery system. Marketed by Henan Kangdi Medical Devices Co., Ltd., this product is identified by NDC 69561-008 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1737778 - lidocaine 4 % Medicated Patch
- RxCUI: 1737778 - lidocaine 0.04 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69561 - Henan Kangdi Medical Devices Co., Ltd.
- 69561-008 - Jengufun Lidocaine Knee Patch
- 69561-008-08 - 42 PATCH in 1 BOX
- 69561-008 - Jengufun Lidocaine Knee Patch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69561-008). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69561-008-08 identifies a specific commercial package of 42 patch in 1 box of Jengufun Lidocaine Knee Patch, a human over the counter drug labeled by Henan Kangdi Medical Devices Co., Ltd.. This patch is formulated for topical use and contains lidocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Henan Kangdi Medical Devices Co., Ltd. on September 10, 2026. The current certification is valid through December 31, 2027.
How is this Henan Kangdi Medical Devices Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69561000808. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.